Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer's disease: a randomized controlled phase 2a trial.
Journal: Nature medicine
Published: April 12, 2024
Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 07, 2021
ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease.
Journal: Neurology
Published: June 28, 2017
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: September 03, 2016
Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: September 29, 2015
Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.
Journal: Archives of neurology
Published: August 16, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026